Treatment Protocol for Rhabdomyolysis
For patients with rhabdomyolysis, aggressive intravenous fluid resuscitation should be the primary treatment, while sodium bicarbonate therapy is not routinely recommended. 1
Initial Assessment and Diagnosis
- Diagnosis is confirmed when serum creatine kinase (CK) level is >1000 U/L or at least 5 times the upper limit of normal 2
- Obtain serum myoglobin, urinalysis (to check for myoglobinuria), and a complete metabolic panel including serum creatinine and electrolytes 2
- Calculate McMahon score on admission - a score of 6 or greater predicts acute kidney injury (AKI) requiring renal replacement therapy 2
Primary Treatment: Fluid Resuscitation
- Early and aggressive fluid replacement using crystalloid solution is the cornerstone for preventing and treating AKI due to rhabdomyolysis 2
- Aim for urine output of approximately 80-100 mL/m²/h (or 4-6 mL/kg/h in smaller patients) 3
- Monitor for signs of volume overload, especially in patients with pre-existing cardiac or renal dysfunction 4
Bicarbonate Therapy: Not Routinely Recommended
- Current evidence does not support routine use of sodium bicarbonate for prevention of AKI in rhabdomyolysis 1
- A recent propensity score-matched cohort study showed that bicarbonate therapy was associated with higher incidence of AKI, higher rate of dialysis dependency, higher 30-day mortality, and longer hospital stays compared to non-bicarbonate therapy 4
- Bicarbonate administration has been associated with sodium and fluid overload, increased lactate and PaCO₂, and decreased serum ionized calcium 3
Mannitol: Not Recommended
- Evidence does not support the use of mannitol in patients with rhabdomyolysis 1
- Conditional recommendation against treatment with mannitol based on very low quality evidence 1
Special Considerations
- Treat underlying electrolyte imbalances according to standard medical management 2
- Monitor serum potassium levels closely and obtain electrocardiograms to identify life-threatening complications of hyperkalemia 5
- In cases of severe acidosis (pH <7.15) associated with tricyclic antidepressant overdose or sodium channel blocker toxicity, sodium bicarbonate may be considered at 1-2 mEq/kg IV boluses until arterial pH >7.45 3
Monitoring During Treatment
- Regularly monitor serum CK levels, renal function, electrolytes, and fluid balance 2
- Watch for signs of compartment syndrome, which may require surgical intervention 1
- Assess for volume overload, which was significantly higher in patients receiving bicarbonate therapy 4
Treatment Algorithm
- Confirm diagnosis with CK >1000 U/L
- Initiate aggressive IV fluid resuscitation with crystalloids
- Target urine output of 80-100 mL/m²/h
- Monitor and correct electrolyte abnormalities
- Avoid routine use of sodium bicarbonate unless specific indications exist (severe acidosis pH <7.15)
- Avoid mannitol administration
- Consider renal replacement therapy if severe AKI develops despite fluid resuscitation
Pitfalls and Caveats
- Excessive fluid administration can lead to volume overload; high-volume fluid therapy (≥3 mL/kg/hr) was associated with worse renal outcomes and higher mortality compared to lower-volume fluid therapy 4
- Bicarbonate therapy may cause metabolic alkalosis and decrease ionized calcium levels 3
- Do not delay treatment while waiting for laboratory confirmation, as early intervention is critical for preventing complications 2